世界の小児専門病院心臓センターで採用され、かつ、日々改定が続けられてすでに15年に及び、世界標準の心カテ及び心臓手術の教科書です。 #メディカルテクニカ #Labtech_Holter #生体情報 #Heart_vest_gTec #Pedcath8 #Mennen_Medical #Vectorcardiography_Labtech_Holter #VitalStream_Caretaker_Medical #Pedcath8_Mennen_Medical #wvelet_algorithm #Piston_Medical_COanalysi
#VitalStream_SOFA_EWS_Decomposition_ECMO_COVID19 #Labtech_Holter_wavelet
#wavelet_Labtech12leadsECG_decomposition_CaretakerMedical #SCD_EWS_proposals
モバイル・スマホ・タブレット・パソコンなどに、12誘導心電図や血行動態などをオンライン・リアルタイムで表示・遠隔表示
2014年5月26日月曜日
Arterial Stiffness
Invasive validation of a new oscillometric device
(Arteriograph) for measuring augmentation index, central
blood pressure and aortic pulse wave velocity
Iva´n G. Horva´ tha, A´ da´m Ne´metha, Zso´ fia Lenkeya, Nicola Alessandrib,
Fabrizio Tufanob, Pa´ l Kisa, Bala´ zs Gasznera and Attila Czira´ kia
Background The importance of measuring aortic
pulse wave velocity (PWVao), aortic augmentation
index (Aix) and central systolic blood pressure
(SBPao) has been shown under different clinical
conditions; however, information on these
parameters is hard to obtain. The aim of this study
was to evaluate the accuracy of a new, easily applicable
oscillometric device (Arteriograph), determining these
parameters simultaneously, against invasive
measurements.
Methods Aortic Aix, SBPao and PWVao were measured
invasively during cardiac catheterization in 16, 55 and
22 cases, respectively, and compared with the values
measured by the Arteriograph.
Results We found strong correlation between the invasively
measured aortic Aix and the oscillometrically measured
brachial Aix on either beat-to-beat or mean value per patient
basis (rU0.9, P<0.001; rU0.94, P<0.001), which allowed
the noninvasive calculation of the aortic Aix without using
generalized transfer function. Similarly strong correlation
(rU0.95, P<0.001) was found between the invasively
measured and the noninvasively calculated central SBPao;
furthermore, the BHS assessment of the paired differences
fulfilled the ‘B’ grading. The PWVao values measured
invasively and by Arteriograph were 9.41W1.8 m/s and
9.46W1.8 m/s, respectively (meanWSD); furthermore, the
Pearson’s correlation was 0.91 (P<0.001). The limits of
agreement were 11.4% for aortic Aix and 1.59 m/s for
PWVao.
Conclusion Aix, SBPao and PWVao, measured
oscillometrically, showed strong correlation with the
invasively obtained values. The observed limits of
agreement are encouragingly low for accepting the method
for clinical use. Our results suggest that the PWVao values,
measured by Arteriograph, are close to the true aortic PWV,
determined invasively. J Hypertens 28:2068–2075 Q 2010
Wolters Kluwer Health | Lippincott Williams & Wilkins.
Journal of Hypertension 2010, 28:2068–2075
Keywords: arterial stiffness, Arteriograph, augmentation index, invasive
measurement, oscillometric method, pulse wave velocity, validation
Abbreviations: Aix-ao, aortic augmentation index; Aix-br, brachial
augmentation index; BP, blood pressure; CAS, coronary artery stenosis; cf
PWV, carotid–femoral pulse wave velocity; GTF, generalized transfer
function; Jug-Sy, Jugulum-Symphisis; PWVao, aortic pulse wave velocity; RT,
return time; SBPao, central systolic blood pressure
aHeart Institute, Medical School, University of Pe´ cs, Pe´ cs, Hungary and
bDepartment of Cardiology, University of Rome La Sapienza, Polo Pontino, Italy
Correspondence to Attila Czira´ ki, Heart Institute, Medical School, University of
Pe´ cs, H-7624 Ifju´sa´g str. 13. Pe´ cs, Hungary
Tel: +36 302177464; e-mail: acziraki@t-online.hu
Received 3 December 2009 Revised 19 May 2010
Accepted 27 May 2010
See editorial comment on page 2003
Introduction
The importance of the parameters (aortic pulse wave
velocity, PWVao; aortic augmentation index, Aix; central
systolic blood pressure, SBPao) describing the arterial
function (stiffness) has been shown on different groups of
patients: end-stage renal disease [1–3], coronary artery
disease [4,5], hypertension [6,7], diabetes [8]) and, on
general, apparently healthy population [9]. Based on
these results, the evaluation of arterial stiffness was
included in the 2007ESH/ESC guidelines for the management
of arterial hypertension, both in evaluating
organ damage and in the cardiovascular risk calculation
of patients with hypertension [10].
However, the examination of the above-mentioned
parameters has not become part of the daily routine in
clinical work so far [10]. A possible cause may be that the
methods used did not allow to determine these
parameters at the same time, were fairly complicated